首页> 美国卫生研究院文献>Indian Journal of Microbiology >Bioactive compounds from marine actinomycetes
【2h】

Bioactive compounds from marine actinomycetes

机译:海洋放线菌的生物活性化合物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Actinomycetes are one of the most efficient groups of secondary metabolite producers and are very important from an industrial point of view. Among its various genera, Streptomyces, Saccharopolyspora, Amycolatopsis, Micromonospora and Actinoplanes are the major producers of commercially important biomolecules. Several species have been isolated and screened from the soil in the past decades. Consequently the chance of isolating a novel actinomycete strain from a terrestrial habitat, which would produce new biologically active metabolites, has reduced. The most relevant reason for discovering novel secondary metabolites is to circumvent the problem of resistant pathogens, which are no longer susceptible to the currently used drugs. Existence of actinomycetes has been reported in the hitherto untapped marine ecosystem. Marine actinomycetes are efficient producers of new secondary metabolites that show a range of biological activities including antibacterial, antifungal, anticancer, insecticidal and enzyme inhibition. Bioactive compounds from marine actinomycetes possess distinct chemical structures that may form the basis for synthesis of new drugs that could be used to combat resistant pathogens.
机译:放线菌是次级代谢产物生产者中效率最高的组之一,从工业角度来看非常重要。在其各种属中,链霉菌,糖多孢菌,扁桃体,微单孢菌和放线菌是商业上重要的生物分子的主要生产者。在过去的几十年中,已经从土壤中分离并筛选出几种物种。因此,从陆地栖息地分离出新的放线菌菌株的机会减少了,该菌株将产生新的具有生物活性的代谢产物。发现新的次生代谢产物最相关的原因是规避了耐药病原体的问题,这些病原体不再对当前使用的药物敏感。据报道,迄今尚未开发的海洋生态系统中存在放线菌。海洋放线菌是新的次生代谢产物的有效生产者,这些次生代谢产物显示出一系列的生物学活性,包括抗菌,抗真菌,抗癌,杀虫和酶抑制作用。来自海洋放线菌的生物活性化合物具有独特的化学结构,这些化学结构可能构成合成新药的基础,这些新药可用于抵抗耐药性病原体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号